Search research articles
Contact Us
Filters
Showing results (181-190 of 195) with videos related to
Page
of 20
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine
|
March 21, 2015
G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin
Rong Qi, Heran Zhang, Lu Xu, et al.
Journal of Clinical Microbiology
|
December 1, 2023
Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus
Zihao Chen, Guanghui Li, Jianwen Situ, et al.
Colloids and Surfaces. B, Biointerfaces
|
May 15, 2013
Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies
Qiang Fu, Jin Sun, Dong Zhang, et al.
Molecular Pharmaceutics
|
January 15, 2015
Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes
Qian Ma, Yingchun Han, Cong Chen, et al.
Journal of Virological Methods
|
August 6, 2022
Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection
Siling Wang, Yangling Wu, Yizhen Wang, et al.
Journal of Virology
|
October 19, 2023
Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant
Hui Sun, Yizhen Wang, Xiuting Chen, et al.
Frontiers in Immunology
|
July 5, 2023
Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency
Dong Ying, Wenxia Niu, Yanling Chen, et al.
Frontiers in Immunology
|
October 7, 2022
Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
Siling Wang, Dinghui Wu, Hualong Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 25, 2024
Structural basis for the synergetic neutralization of hepatitis E virus by antibody-antibody interaction
Minghua Zheng, Lizhi Zhou, Yang Huang, et al.
Cell Reports
|
May 20, 2022
Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
Siling Wang, Hui Sun, Yali Zhang, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 195) with videos related to
Sort By:
Page
of 20
Nanomedicine : Nanotechnology, Biology, and Medicine
|
March 21, 2015
G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin
Rong Qi, Heran Zhang, Lu Xu, et al.
Journal of Clinical Microbiology
|
December 1, 2023
Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus
Zihao Chen, Guanghui Li, Jianwen Situ, et al.
Colloids and Surfaces. B, Biointerfaces
|
May 15, 2013
Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies
Qiang Fu, Jin Sun, Dong Zhang, et al.
Molecular Pharmaceutics
|
January 15, 2015
Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes
Qian Ma, Yingchun Han, Cong Chen, et al.
Journal of Virological Methods
|
August 6, 2022
Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection
Siling Wang, Yangling Wu, Yizhen Wang, et al.
Journal of Virology
|
October 19, 2023
Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant
Hui Sun, Yizhen Wang, Xiuting Chen, et al.
Frontiers in Immunology
|
July 5, 2023
Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency
Dong Ying, Wenxia Niu, Yanling Chen, et al.
Frontiers in Immunology
|
October 7, 2022
Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
Siling Wang, Dinghui Wu, Hualong Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 25, 2024
Structural basis for the synergetic neutralization of hepatitis E virus by antibody-antibody interaction
Minghua Zheng, Lizhi Zhou, Yang Huang, et al.
Cell Reports
|
May 20, 2022
Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
Siling Wang, Hui Sun, Yali Zhang, et al.
Page
of 20